Ofloxacin provides broad-spectrum fluoroquinolone coverage that spans both Gram-negative and atypical pathogens, positioning it as a versatile injectable and oral antibiotic in veterinary practice. Its utility in aquaculture for fish vibriosis and in poultry for chronic respiratory disease has driven steady demand across Asian and Latin American veterinary markets.
| CAS Number | 82419-36-1 |
|---|---|
| Molecular Formula | C18H20FN3O4 |
| Molecular Weight | 361.4 |
| Pharmacopoeia | USP, EP |
| Packaging | 25 KG/DRUM |
Ofloxacin is a second-generation fluoroquinolone antibiotic for veterinary use, offering broad-spectrum activity against both Gram-negative and Gram-positive bacteria. It achieves high concentrations in tissues and body fluids, making it effective for systemic bacterial infections in livestock and aquaculture.
Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV. With excellent bioavailability (98%) and good tissue penetration, it provides reliable bactericidal activity across multiple body systems. Widely used in poultry, swine, cattle, and aquaculture for the treatment of systemic bacterial infections.
| Purity | As per USP monograph |
|---|---|
| Residual Solvents | Compliant with ICH Q3C |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |